You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 9, September 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Public Health
 •Substance Abuse/ Alcoholism
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Functional Neuropeptide Y Leu7Pro Polymorphism Associated With Alcohol Dependence in a Large Population Sample From the United States

Jaakko Lappalainen, MD, PhD; Henry R. Kranzler, MD; Robert Malison, MD; Lawrence H. Price, MD; Christopher Van Dyck, MD; Robert A. Rosenheck, MD; Joyce Cramer, BS; Steven Southwick, MD; Dennis Charney, MD; John Krystal, MD; Joel Gelernter, MD

Arch Gen Psychiatry. 2002;59:825-831.

Background  Quantitative trait locus studies, and observations in animals manipulated for the neuropeptide Y (NPY) gene suggest that variation within this gene may contribute to alcoholism. A recent population study suggested that the Pro7 allele of a functional NPY polymorphism (Leu7Pro) may be associated with increased alcohol consumption. We tested whether the Pro7 allele is associated with alcohol dependence in European Americans (EA).

Methods  The design was a population study comparing the Leu7Pro allele frequencies in alcohol-dependent subjects and controls. Population stratification potential and diagnostic specificity was studied by genotyping individuals from additional populations and psychiatric diagnostic classes. We studied 2 independently collected samples of EA alcohol-dependent subjects (sample 1, n = 307; sample 2, n = 160) and a sample of psychiatrically screened EA controls (n = 202); 8 population samples, including African Americans and European Americans (total n = 551); and 4 samples of individuals with Alzheimer disease, schizophrenia, posttraumatic stress disorder, and major depression (total n = 502). The main outcome measure was the difference in Leu7Pro allele frequencies between alcohol-dependent subjects and controls.

Results  The frequency of the Pro7 allele was higher in the alcohol-dependent subjects (sample 1, 5.5%; sample 2, 5.0%) compared with the screened EA controls (2.0%) (sample 1 vs controls, P = .006; sample 2 vs controls, P = .03). The attributable fraction (excess morbidity) in similarly affected populations, owing to the Pro7 allele, was estimated to be 7.3%. The frequency of the Pro7 allele was equal or lower in the population samples, as compared with the screened EA controls (0%-2.2%), with 1 exception (Bedouins). We found no significant evidence that the association of the Pro7 allele with alcohol dependence was due to an association with a comorbid psychiatric disorder.

Conclusions  These results suggest that the NPY Pro7 allele is a risk factor for alcohol dependence. This is only the second specific genetic mechanism ever identified that modulates risk for alcohol dependence.


From the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn (Drs Lappalainen, Malison, Van Dyck, Rosenheck, Southwick, Charney, Krystal, and Gelernter, and Ms Cramer), the Veterans Administration Connecticut Healthcare System, West Haven (Drs Lappalainen, Rosenheck, Southwick, Krystal, and Gelernter, and Ms Cramer), the Department of Psychiatry, University of Connecticut School of Medicine, Farmington (Dr Kranzler); and Butler Hospital and the Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, RI (Dr Price).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Emerging approaches to managing alcohol dependence
SWIFT
Am J Health Syst Pharm 2007;64:S12-S22.
ABSTRACT | FULL TEXT  

The Genetics of Addictions: Uncovering the Genes
Goldman et al.
Focus 2006;4:401.
ABSTRACT | FULL TEXT  

Categorical and Continuous Models of Liability to Externalizing Disorders: A Direct Comparison in NESARC
Markon and Krueger
Arch Gen Psychiatry 2005;62:1352-1359.
ABSTRACT | FULL TEXT  

INCREASED FASTING PLASMA GHRELIN LEVELS DURING ALCOHOL ABSTINENCE
KIM et al.
Alcohol Alcohol 2005;40:76-79.
ABSTRACT | FULL TEXT  

Drug Addiction
Cami and Farre
NEJM 2003;349:975-986.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.